An Exploratory study of Amapinib for patients with advanced esophagus cancer .~Eligible are patients with advanced esophagus cancer. Apatinib (500mg) is given daily as follows:~Metastasis after primary treatment : Apatinib + yew + platinum. Local recurrence after previous surgery/radiotherapy: Apatinib alone or in combination with platinum-based chemotherapy One therapy cycle has 28 days. Tumor response is evaluated every 2 cycles.
An Exploratory study of Amapinib for patients with advanced esophagus cancer .